A retrospective multicenter analysis of elderly Hodgkin lymphoma: Outcomes and prognostic factors in the modern era

Blood

Volumn 119, Issue 3, 2012, Pages 692-695

  Evens, Andrew M ^a   Helenowski, Irene ^b   Ramsdale, Erika ^c   Nabhan, Chadi ^d   Karmali, Reem ^e   Hanson, Britt ^f   Parsons, Benjamin ^d   Smith, Scott ^f   Larsen, Annette ^a   McKoy, June M ^b   Jovanovic, Borko ^b   Gregory, Stephanie ^f   Gordon, Leo I ^g   Smith, Sonali M ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; EARLY MODERN PERIOD; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HODGKIN DISEASE; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

EID: 84862909244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-378414     Document Type: Article

References (27)

1. Evens AM, Sweetenham JW, Horning SJ. Hodgkin lymphoma in older patients: an uncommon disease in need of study. Oncology (Williston Park). 2008;22(12):1369-1379.
2. Eghbali H, Creemers G, et al. Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F Trial. Blood. 2005;106(11S):814A.
3. Erdkamp FL, Breed WP, Bosch LJ, et al. Hodgkin disease in the elderly. A registry-based analysis. Cancer. 1992;70:830-834.
4. Levis A, Depaoli L, Urgesi A, et al. Probability of cure in elderly Hodgkin's disease patients. Haematologica. 1994;79(1):46-54.
5. Mir R, Anderson J, Strauchen J, et al. Hodgkin disease in patients 60 years of age or older: histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer. 1993;71(5):1857-1866. (Pubitemid 23067406)
6. Roy P, Vaughan Hudson G, Vaughan Hudson B, Esteve J, Swerdlow AJ. Long-term survival in Hodgkin's disease patients: a comparison of relative survival in patients in trials and those recorded in population-based cancer registries. Eur J Cancer. 2000;36(3):384-389. (Pubitemid 30116736)
7. Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR. Hodgkin's disease in the elderly: a population-based study. Br J Haematol. 2002;119(2):432-440. (Pubitemid 35365495)
8. Weekes CD, Vose JM, Lynch JC, et al. Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. J Clin Oncol. 2002;20(4):1087-1093. (Pubitemid 34141854)
9. Boll B, Bredenfeld H, Gorgen H, et al. Phase II study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma [published online ahead of print September 13, 2011]. Blood. doi:1182/blood-2011-07-368167.
10. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339(21):1506-1514.
11. Swerdlow SH, Harris NL. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed). Lyon, France: International Agency for Research on Cancer; 2008.
12. Mistry R, Gokhman I, Bastani R, et al. Measuring medical burden using CIRS in older veterans enrolled in UPBEAT, a psychogeriatric treatment program: a pilot study. J Gerontol A Biol Sci Med Sci. 2004;59(10):1068-1075. (Pubitemid 39441798)
13. Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc. 1995;43(2):130-137.
14. Aapro M, Extermann M, Repetto L. Evaluation of the elderly with cancer. Ann Oncol. 2000;11(suppl 3):223-229.
15. Repetto L, Comandini D. Cancer in the elderly: assessing patients for fitness. Crit Rev Oncol Hematol. 2000;35(3):155-160.
16. Cox D. Regression models and life tables. J Royal Statist Soc B. 1972;34:187-220.
17. Enblad G, Gustavsson A, Sundstrom C, Glimelius B. Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy. Acta Oncol. 2002;41(7):659-667. (Pubitemid 36106211)
18. Landgren O, Algernon C, Axdorph U, et al. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica. 2003;88(4):438-444. (Pubitemid 36547130)
19. van Spronsen DJ, Janssen-Heijnen ML, Lemmens VE, et al. Independent prognostic effect of co-morbitity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer. 2005;41(7):1051-1057. (Pubitemid 40602858)
20. Levis A, Anselmo AP, Ambrosetti A, et al. VEPEMB in elderly Hodgkin's lymphoma patients: results from an Intergruppo Italiano Linfomi (IIL) study. Ann Oncol. 2004;15(1):123-128. (Pubitemid 38139613)
21. Ballova V, Ruffer JU, Haverkamp H, et al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Ann Oncol. 2005;16(1):124-131. (Pubitemid 40124489)
22. Diaz-Pavon JR, Cabanillas F, Majlis A, Hagemeister FB. Outcome of Hodgkin's disease in elderly patients. Hematol Oncol. 1995;13(1):19-27.
23. Guinee VF, Giacco GG, Durand M, et al. The prognosis of Hodgkin's disease in older adults. J Clin Oncol. 1991;9(6):947-953.
24. Martin WG, Ristow KM, Habermann TM, Colgan JP, Witzig TE, Ansell SM. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol. 2005;23(30):7614-7620. (Pubitemid 46291825)
25. Azoulay E, Herigault S, Levame M, et al. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med. 2003;31(5):1442-1448. (Pubitemid 36583857)
26. Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood. 2008;111(6):2977-2983.
27. Proctor SJ, White J, Jones GL. An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Eur J Haematol Suppl. 2005;(66):63-67. (Pubitemid 40873980)